The closing price of Precigen Inc (NASDAQ: PGEN) was $1.54 for the day, up 1.32% from the previous closing price of $1.52. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 1285182 shares were traded.
Ratios:
Our analysis of PGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 2.83. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.
On February 25, 2021, Stifel started tracking the stock assigning a Buy rating and target price of $13.Stifel initiated its Buy rating on February 25, 2021, with a $13 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 28 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 380.85M and an Enterprise Value of 314.48M. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.71 while its Price-to-Book (P/B) ratio in mrq is 2.67. Its current Enterprise Value per Revenue stands at 46.52 whereas that against EBITDA is -4.07.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is 1.3640, while the 200-Day Moving Average is calculated to be 1.3020.
Shares Statistics:
PGEN traded an average of 1.18M shares per day over the past three months and 1.31M shares per day over the past ten days. A total of 208.15M shares are outstanding, with a floating share count of 125.04M. Insiders hold about 49.77% of the company’s shares, while institutions hold 30.46% stake in the company. Shares short for PGEN as of Feb 15, 2024 were 17.54M with a Short Ratio of 14.90, compared to 18.84M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.05% and a Short% of Float of 11.87%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.08, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.33 and -$0.41 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.31, with 4 analysts recommending between -$0.25 and -$0.39.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $7.5M, while the lowest revenue estimate was $5M, resulting in an average revenue estimate of $6.7M. In the same quarter a year ago, actual revenue was $26.91M, down -75.10% from the average estimate.
